Five recent CRISPR drug target discoveries
This article highlights five of the latest findings revealed using CRISPR that could be used in the development or design of new therapies.
List view / Grid view
Genomics is the branch of molecular biology concerned with the structure, function, evolution, and mapping of genomes.
This article highlights five of the latest findings revealed using CRISPR that could be used in the development or design of new therapies.
US researchers, using genome sequencing, put forward the Nile rat as the new model organism for diabetes research.
US researchers have engineered bacteriophages to deliver CRISPR-Cas payloads for targeted editing of a bacterium.
A research team at the University of Exeter have found that the unexplored genomic control regions yield the key to finding causes of Congenital Hyperinsulinism.
Researchers show how monkeypox mutations cause virus to replicate, spread faster.
Researchers from the University of California have developed the first pre-clinical model of appendiceal cancer, containing all elements of the tumour.
The researchers used a zebrafish model to test mutations in Mycn, a gene which causes Feingold syndrome.
The study’s findings have important implications for better understanding the neurological basis for ASD and developing effective therapies for patients.
In this Q&A, Dr Stephen Jones from Vilnius University Life Sciences Center discusses his work on the recent developments in genome editing tools at the university.
Scientists shed light on how genetic architecture in human retina cells determine gene expression, tissue-specific function, and disease phenotype in blinding diseases.
A new MIT study highlights ailing neurons may activate an inflammatory response from the brain’s microglia immune cells.
Unlike other mitochondrial diseases, a newly discovered form leads to hyperactive mitochondria, causing patients to have low body weight despite excessive food intake.
12 October 2022 | By Unchained Labs
Watch this on-demand webinar to see first-hand data results demonstrating the power and flexibility of Unagi for nucleic acids, LNPs and AAVs.
A potential Zika virus vaccine, developed by deleting part of the Zika genome that codes for the viral shell, was effective and safe in mice.
A newly developed AAV has shown promise at delivering gene therapies to the brain in mice and non-human primates.